The apparent disconnect between transcript and protein levels suggests that the turnover/stability of Ago2 protein is tightly and differentially regulated in breast cancer subtypes, as has previously been demonstrated in ER positive cells, which can in turn influence growth rates [29]. This evidence concerns the gene AGO2 and breast carcinoma.